Abstract:Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are complex, multifactorial disorders that lead to chronic and relapsing intestinal inflammation. The exact etiology remains unknown, however multiple factors including the environment, genetic, dietary, mucosal immunity, and altered microbiome structure and function play important roles in disease onset and progression. Supporting this notion that the gut microbiota plays a pivotal role in IBD pathogenesis, studies in gnotobiotic mice have shown that mouse models of intestinal inflammation require a microbial community to develop colitis. Additionally, antimicrobial therapy in some IBD patients will temporarily induce remission further demonstrating an association between gut microbes and intestinal inflammation. Finally, a dysfunctional intestinal epithelial barrier is also recognized as a key pathogenic factor in IBD. The intestinal epithelium serves as a barrier between the luminal environment and the mucosal immune system and guards against harmful molecules and microorganisms while being permeable to essential nutrients and solutes. Beneficial (i.e., mutualists) bacteria promote mucosal health by strengthening barrier integrity, increasing local defenses (mucin and IgA production) and inhibiting pro-inflammatory immune responses and apoptosis to promote mucosal homeostasis. In contrast, pathogenic bacteria and pathobionts suppress expression and localization of tight junction proteins, cause dysregulation of apoptosis/proliferation and increase pro-inflammatory signaling that directly damages the intestinal mucosa. This review article will focus on the role of intestinal epithelial cells (IECs) and the luminal environment acting as mediators of barrier function in IBD. We will also share some of our translational observations of interactions between IECs, immune cells, and environmental factors contributing to maintenance of mucosal homeostasis, as it relates to GI inflammation and IBD in different animal models.

The Regulation of Intestinal Inflammation and Cancer Development by Type 2 Immune Responses

Intestinal barrier function: Molecular regulation and disease pathogenesis

Epithelial regulation of microbiota-immune cell dynamics

Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease

Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease

The Protective Role of Type I Interferons in the Gastrointestinal Tract

Intestinal barrier: Molecular pathways and modifiers

Immune cell-derived signals governing epithelial phenotypes in homeostasis and inflammation

Cytokine-Mediated Crosstalk between Immune Cells and Epithelial Cells in the Gut

Innate Lymphoid Cells as Regulators of Epithelial Integrity: Therapeutic Implications for Inflammatory Bowel Diseases

TH17 Cell and Epithelial Cell Crosstalk during Inflammatory Bowel Disease and Carcinogenesis

The intestinal immunoendocrine axis: novel cross-talk between enteroendocrine cells and the immune system during infection and inflammatory disease

Epithelial-immune cell crosstalk for intestinal barrier homeostasis

Sentinels at the frontline: the role of intraepithelial lymphocytes in inflammatory bowel disease

Regulatory Lymphocytes and Intestinal Inflammation

Novel cellular interactions and networks involving the intestinal immune system and its microenvironment

Context-Dependent Regulation of Type17 Immunity by Microbiota at the Intestinal Barrier

Immunoregulation of intestinal epithelial cells and its relevance to inflammatory bowel disease

Epithelial Barriers in Intestinal Inflammation

Innate immunity in the small intestine

Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease